Aviva Industries Limited has completed the allotment of 48.40 lakh fully convertible equity warrants to three non-promoter investors on January 13, 2026, marking the fourth tranche of its preferential issue program. The board meeting, held at the company's registered office, approved the allotment at an issue price of ₹28.00 per warrant, including a premium of ₹18.00 per warrant.

Warrant Allotment Details

The company allotted warrants to three non-promoter category investors following the special resolution passed by members in the Annual General Meeting on September 30, 2025, and subsequent in-principle approval from BSE on January 02, 2026.

Allottee Distribution

The warrants were distributed among three individual investors, all classified under the non-promoter category:

*Calculated assuming full exercise of warrants and consequent allotment of equity shares.

Conversion Terms and Payment Structure

The fully convertible equity warrants carry specific terms for conversion into equity shares. Each warrant is convertible into one fully paid-up equity share with a face value of ₹10.00 each. The conversion option must be exercised within a maximum period of 18 months from the allotment date.

The payment structure follows SEBI regulations, with allottees required to pay 25% of the consideration amount upfront along with the application. The company has confirmed receipt of this initial payment from all proposed allottees. The remaining 75% becomes payable when allottees exercise their conversion option.

Regulatory Compliance

The allotment was conducted in accordance with SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, and Chapter V of SEBI (ICDR) Regulation 2018. The company has fulfilled all disclosure requirements under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The board meeting commenced at 6:00 PM and concluded at 6:30 PM on January 13, 2026. Currently, there is no change in the paid-up share capital of the company as the warrants have been allotted but not yet converted into equity shares. The number of equity shares to be allotted upon warrant exercise will be subject to appropriate adjustments as permitted under applicable rules, regulations, and laws.

Aviva Industries Limited has completed the allotment of 32,40,000 fully convertible equity warrants on a preferential basis to two non-promoter investors on January 08, 2026. The board of directors approved this allotment during their meeting held at the company's registered office, generating a total consideration of ₹90.72 crores.

Warrant Allotment Details

The warrants were issued at ₹28.00 per warrant, which includes a premium of ₹18.00 per warrant. The allotment was made in the first tranche following the special resolution passed by members during the Annual General Meeting on September 30, 2025, and the in-principle approval granted by BSE on January 02, 2026.

Allottee Information

The warrants have been allocated equally between two non-promoter category investors:

*Post-issue shareholding calculated assuming full exercise of warrants and consequent allotment of equity shares.

Conversion Terms and Compliance

Each warrant is convertible into an equivalent number of fully paid-up equity shares with a face value of ₹10.00 each. The warrant holders have a maximum period of 18 months from the allotment date to exercise their conversion option. The company has received 25% of the consideration amount upfront from the proposed allottees, as required under SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018.

The remaining 75% of the consideration amount will be payable by the allottees upon exercising their conversion option. The allotment was conducted in accordance with Chapter V of SEBI (ICDR) Regulation 2018 and the Companies Act, 2013. Since warrants have been allotted rather than equity shares, there is currently no change in the company's paid-up share capital.

Regulatory Framework

The allotment process was completed following all necessary regulatory approvals and compliance requirements. The board meeting commenced at 4:30 PM and concluded at 5:00 PM on January 08, 2026. The number of equity shares to be allotted upon warrant exercise will be subject to appropriate adjustments as permitted under applicable rules, regulations, and laws.